I was able to lose about 10lbs or so last year
Systolic blood pressure reduction with tirzepatide across SURPASS program Across the SURPASS program, SBP reductions ranged from 4.2 to 12.6 mmHg in participants receiving tirzepatide
10.3389/fpls.2016.00741 116 LiB.PinchH.BirtD
Tesamorelin activates growth hormone release a process that: Unlike general weight-loss options, medications like Tesamorelin targets where it matters most inside your abdomen, where fat poses the greatest health risk
During semaglutide therapy, many patients experience marked decreases in appetite and early satiety, which can lead to reduced overall food intake
dopo 208 settimane nei pazienti trattati con la semaglutide erano migliorati tutti i parametri metabolici: peso (10,2 %), circonferenza vita (7,7 cm) rapporto girovita-altezza (6,9 %)